What does this research mean for the field?

Telehealth obesity treatment using anti-obesity medications (AOMs) leads to sustained weight loss over 24 months, comparable to clinical trial outcomes. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To evaluate the long-term outcomes of obesity medications in a telehealth setting over 24 months.

March 4, 2026

Twenty-Four Month Outcomes From a Real-World Telehealth Obesity Treatment Clinic Using Obesity Medications.

Key Points

To evaluate the long-term outcomes of obesity medications in a telehealth setting over 24 months.
Real-world analysis of patient weight loss data over 24 months
Assessment of weight loss at 18 and 24 months
Comparison of weight loss outcomes to clinical trial data
Weight losses at 18 and 24 months were comparable to clinical trials
Continued weight loss occurred between 18 and 24 months
Sustained engagement with telemedicine supports ongoing weight loss

Abstract

This real-world analysis found 18- and 24-month weight losses comparable to those demonstrated in clinical trials, supporting the long-term efficacy of AOMs provided by a telemedicine weight management clinic. Continued weight loss was demonstrated between 18 and 24 months, suggesting sustained engagement with AOMs and a telemedicine weight management clinic support continued weight loss in the long term.

Twenty-Four Month Outcomes From a Real-World Telehealth Obesity Treatment Clinic Using Obesity Medications.

Key Points

Abstract

Cite This Study